These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2890681)

  • 1. Benzodiazepines: selective administration.
    Ananth J
    J Affect Disord; 1987; 13(2):99-108. PubMed ID: 2890681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].
    Goffinet S
    Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A guide to benzodiazepine selection. Part I: Pharmacological aspects.
    Teboul E; Chouinard G
    Can J Psychiatry; 1990 Nov; 35(8):700-10. PubMed ID: 1980860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on the mode of action of benzodiazepines.
    Leonard BE
    J Psychiatr Res; 1993; 27 Suppl 1():193-207. PubMed ID: 7908333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new group of anxiolytic drugs with a mechanism of action different from that of benzodiazepine derivatives].
    Kostowski W; Płaźnik A
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1647-9, 1683. PubMed ID: 2908340
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurobiologic basis of anxiety and its treatment.
    Salzman C; Miyawaki EK; le Bars P; Kerrihard TN
    Harv Rev Psychiatry; 1993; 1(4):197-206. PubMed ID: 9384849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current hypotheses of the central mechanism of action of benzodiazepine tranquilizers].
    Bouchard LP; Llorca PM; Wolf MA
    Can J Psychiatry; 1991 Nov; 36(9):660-6. PubMed ID: 1685351
    [No Abstract]   [Full Text] [Related]  

  • 8. The GABAA/benzodiazepine receptor: implications for the molecular basis of anxiety.
    Breier A; Paul SM
    J Psychiatr Res; 1990; 24 Suppl 2():91-104. PubMed ID: 1980704
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacotherapy with benzodiazepines: basic principles and new developments].
    Möhler H
    Praxis (Bern 1994); 1998 Feb; 87(6):186-90. PubMed ID: 9531812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions.
    Bradwejn J
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S109-13. PubMed ID: 7905780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future directions in anxiolytic pharmacotherapy.
    Kunovac JL; Stahl SM
    Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligands for the benzodiazepine binding site--a survey.
    Teuber L; Wätjens F; Jensen LH
    Curr Pharm Des; 1999 May; 5(5):317-43. PubMed ID: 10213798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Excerpts from the clinical-pharmacologic and clinical studies of Grandaxin].
    Szegó J; Somogyi M; Papp E
    Acta Pharm Hung; 1993 Mar; 63(2):91-8. PubMed ID: 8100114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The mechanism of action of benzodiazepine and its consequences for therapy].
    Cugurra F
    Clin Ter; 1992 Apr; 140(4):331-43. PubMed ID: 1350239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New anxiolytics in development.
    Mosconi M; Chiamulera C; Recchia G
    Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction. The multiplicity of uses of benzodiazepines.
    Lapierre YD
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S101. PubMed ID: 7905779
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advances in clinical treatment of anxiety disorders].
    Yu Z; Yian H
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Apr; 25(2):116-9. PubMed ID: 1354152
    [No Abstract]   [Full Text] [Related]  

  • 18. Are all benzodiazepines clinically equivalent?
    Lapierre YD
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):641-6. PubMed ID: 6141607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep disorders and anxiety: biochemical antecedents and pharmacological consequences.
    Leonard BE
    J Psychosom Res; 1994; 38 Suppl 1():69-87. PubMed ID: 7799254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of molecular substrate for the attenuation of anxiety: a step toward the development of better anti-anxiety drugs.
    Rudolph U
    ScientificWorldJournal; 2001 May; 1():192-3. PubMed ID: 12805666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.